Aficamten Impurity 7 | CAS 3061106-40-6 - Request Quote
Aficamten Impurity 7
| SZ CAT No: | SZ-A222010 |
| CAS No | 3061106-40-6 |
| Mol.F. | C18H19N5O3 |
| Mol.Wt. |
353.4 |
| Inv. Status |
Synthesis on demand |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Aficamten Impurity 7 is chemically N-((1R)-5-(5-ethyl-1,2,4-oxadiazol-3-yl)-3-hydroxy-2,3-dihydro-1H-inden-1-yl)-1-methyl-1H-pyrazole-4-carboxamide. Aficamten Impurity 7 is supplied with detailed characterization data compliant with regulatory guideline. Aficamten Impurity 7 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Aficamten.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
Buy 3061106-40-6
Purchase 3061106-40-6
Order 3061106-40-6
Enquire 3061106-40-6
price of 3061106-40-6
3061106-40-6 Supplier
3061106-40-6 Manufacturer
3061106-40-6 Exporter
buy high quality Aficamten Impurity 7
Purchase Aficamten Impurity 7
Aficamten Impurity 7 suppliers
Aficamten Impurity 7 manufacturers
Aficamten Impurity 7 price
Order Aficamten Impurity 7
Enquire Aficamten Impurity 7
Aficamten Impurity 7 cost
Aficamten Impurity 7 Supplier
Aficamten Impurity 7 Distributor
Aficamten Impurity 7 for Method Validation
Aficamten Reference Standard
Aficamten Impurity 7 for ANDA Filing
Aficamten Impurity 7 for Forced Degradation Studies
Aficamten Impurity 7 Identification Standards
Aficamten Impurity 7 for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.